Dawkins Fitzroy W, Gordeuk Victor R, Snively Beverly M, Lovato Laura, Barton James C, Acton Ronald T, McLaren Gordon D, Leiendecker-Foster Catherine, McLaren Christine E, Adams Paul C, Speechley Mark, Harris Emily L, Jackson Sharon, Thomson Elizabeth J
Division of Hematology/Oncology, Department of Medicine, Howard University, Washington, DC, USA.
Am J Med. 2007 Aug;120(8):734.e1-9. doi: 10.1016/j.amjmed.2006.05.049. Epub 2007 Mar 21.
We sought to determine the prevalence of elevated measures of iron status in African Americans and whether the combination of serum ferritin concentration >200 microg/L for women or >300 microg/L for men and transferrin saturation in the highest quartile represents increased likelihood of mutation of HFE, self-reported iron overload or self-reported liver disease.
A cross-sectional observational study of 27,224 African Americans > or =25 years of age recruited in a primary care setting was conducted as part of the multi-center, multi-ethnic Hemochromatosis and Iron Overload Screening (HEIRS) Study. Measurements included serum ferritin concentration, transferrin saturation, testing for HFE C282Y and H63D, and self-reported iron overload and liver disease.
Serum ferritin concentration >200 microg/L for women or >300 microg/L for men occurred in 5263 (19.3%) of African Americans, while serum ferritin concentration in this range with highest-quartile transferrin saturation (>29% women; >35% men) occurred in 1837 (6.7%). Adjusted odds of HFE mutation (1.76 women, 1.67 men), self-reported iron overload (1.97 women, 2.88 men), or self-reported liver disease (5.18 women, 3.73 men) were greater with elevated serum ferritin concentration and highest-quartile transferrin saturation than with nonelevated serum ferritin concentration (each P <.05).
Serum ferritin concentration >200 microg/L for women or >300 microg/L for men in combination with transferrin saturation >29% for women or >35% for men occurs in approximately 7% of adult African American primary care patients. Patients with this combination of iron test results should be evaluated for increased body iron stores or liver disease.
我们试图确定非裔美国人中铁状态指标升高的患病率,以及血清铁蛋白浓度女性>200μg/L或男性>300μg/L且转铁蛋白饱和度处于最高四分位数的组合是否意味着遗传性血色素沉着症基因(HFE)突变、自我报告的铁过载或自我报告的肝病的可能性增加。
作为多中心、多种族血色素沉着症和铁过载筛查(HEIRS)研究的一部分,我们在初级保健机构中对27224名年龄≥25岁的非裔美国人进行了一项横断面观察性研究。测量指标包括血清铁蛋白浓度、转铁蛋白饱和度、HFE C282Y和H63D检测,以及自我报告的铁过载和肝病情况。
5263名(19.3%)非裔美国人女性血清铁蛋白浓度>200μg/L或男性>300μg/L,而血清铁蛋白浓度在此范围内且转铁蛋白饱和度处于最高四分位数(女性>29%;男性>35%)的有1837名(6.7%)。与血清铁蛋白浓度未升高相比,血清铁蛋白浓度升高且转铁蛋白饱和度处于最高四分位数时,HFE突变(女性为1.76,男性为1.67)、自我报告的铁过载(女性为1.97,男性为2.88)或自我报告的肝病(女性为5.18,男性为3.73)的校正比值更高(各P<0.05)。
在成年非裔美国初级保健患者中,约7%的人存在女性血清铁蛋白浓度>200μg/L或男性>300μg/L且女性转铁蛋白饱和度>29%或男性>35%的情况。对于铁检测结果为这种组合的患者,应评估其体内铁储存增加或肝病的情况。